Can chronic hyperglycemia and insulin resistance contribute to cognitive decline and neurodegeneration?

Chronic hyperglycemia and insulin resistance are biologically and clinically relevant contributors to brain aging, acting through overlapping metabolic, vascular, and oxidative pathways. The overall evidence supports the claim, while the neuron-specific causal pathway remains less directly established than the vascular and oxidative pathways.

Vascular and oxidative effects

• Chronic hyperglycemia promotes reactive oxygen species through excess mitochondrial electron transport, glucose auto-oxidation, NADPH oxidase activation, AGE–RAGE signaling, and polyol-pathway depletion of NADPH/glutathione defenses. These processes can impair endothelial nitric-oxide signaling, pericyte function, blood–brain-barrier tight junctions, and cerebral perfusion.
• Clinical findings support relevance to cerebral small-vessel disease: higher HbA1c, particularly above 6.51%, predicted greater 2-year white-matter-hyperintensity progression in older adults. In older nondiabetic adults, HOMA-IR ≥2.80 was associated with greater overall small-vessel-disease burden (adjusted OR 3.74, 95% CI 1.63–5.08).
• Insulin resistance can also promote oxidative stress through mitochondrial dysfunction, lipid peroxidation, inflammatory signaling, and AGE–RAGE activity.

Neuronal insulin signaling and cognition

• Impaired insulin-receptor–IRS-1–PI3K–AKT signaling, including inhibitory IRS-1 serine phosphorylation, is documented in Alzheimer-vulnerable brain regions and correlates with poorer memory and global cognition. Hyperglycemia and systemic insulin resistance plausibly worsen this cerebral insulin-responsive dysfunction through metabolic, oxidative, and vascular stress.
• Oxidative stress has prospective links to neurodegenerative outcomes: in ESTHER, high urinary F2-isoprostanes predicted approximately 45% greater incident-dementia risk over about 14 years; plasma nitrotyrosine predicted Alzheimer conversion in an older cohort with major depressive disorder. Sustained HbA1c above 6.5% also predicted faster decline in global cognition, memory, and executive function.

Bottom line

• For a 77-year-old man, persistent dysglycemia and insulin resistance are credible, modifiable contributors to cerebral microvascular injury, oxidative stress, and cognitive vulnerability. Their contribution is multifactorial—not a sole cause of neurodegeneration—and is especially relevant alongside blood-pressure, adiposity, and broader vascular risk management.